Skip to main content
Journal cover image

AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFIC T CELL ENGAGER (BITE (R)) MOLECULE FOR THE TREATMENT OF GLIOBLASTOMA (GBM): PLANNED INTERIM ANALYSIS IN RECURRENT GBM (RGBM)

Publication ,  Conference
Rosenthal, MA; Balana, C; van Linde, ME; Sayehli, C; Fiedler, WM; Wermke, M; Massard, C; Mellinghoff, IK; Khasraw, M; Ang, A; Rasmussen, E ...
Published in: NEURO-ONCOLOGY
November 1, 2019

Duke Scholars

Published In

NEURO-ONCOLOGY

EISSN

1523-5866

ISSN

1522-8517

Publication Date

November 1, 2019

Volume

21

Start / End Page

283 / 283

Location

Phoenix, AZ

Publisher

OXFORD UNIV PRESS INC

Conference Name

24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rosenthal, M. A., Balana, C., van Linde, M. E., Sayehli, C., Fiedler, W. M., Wermke, M., … Cloughesy, T. F. (2019). AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFIC T CELL ENGAGER (BITE (R)) MOLECULE FOR THE TREATMENT OF GLIOBLASTOMA (GBM): PLANNED INTERIM ANALYSIS IN RECURRENT GBM (RGBM). In NEURO-ONCOLOGY (Vol. 21, pp. 283–283). Phoenix, AZ: OXFORD UNIV PRESS INC.
Rosenthal, Mark A., Carmen Balana, Myra E. van Linde, Cyrus Sayehli, Walter M. Fiedler, Martin Wermke, Christophe Massard, et al. “AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFIC T CELL ENGAGER (BITE (R)) MOLECULE FOR THE TREATMENT OF GLIOBLASTOMA (GBM): PLANNED INTERIM ANALYSIS IN RECURRENT GBM (RGBM).” In NEURO-ONCOLOGY, 21:283–283. OXFORD UNIV PRESS INC, 2019.
Rosenthal MA, Balana C, van Linde ME, Sayehli C, Fiedler WM, Wermke M, et al. AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFIC T CELL ENGAGER (BITE (R)) MOLECULE FOR THE TREATMENT OF GLIOBLASTOMA (GBM): PLANNED INTERIM ANALYSIS IN RECURRENT GBM (RGBM). In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2019. p. 283–283.
Rosenthal MA, Balana C, van Linde ME, Sayehli C, Fiedler WM, Wermke M, Massard C, Mellinghoff IK, Khasraw M, Ang A, Rasmussen E, Kast J, Stienen S, Cloughesy TF. AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFIC T CELL ENGAGER (BITE (R)) MOLECULE FOR THE TREATMENT OF GLIOBLASTOMA (GBM): PLANNED INTERIM ANALYSIS IN RECURRENT GBM (RGBM). NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2019. p. 283–283.
Journal cover image

Published In

NEURO-ONCOLOGY

EISSN

1523-5866

ISSN

1522-8517

Publication Date

November 1, 2019

Volume

21

Start / End Page

283 / 283

Location

Phoenix, AZ

Publisher

OXFORD UNIV PRESS INC

Conference Name

24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences